PubMed2 min read
Dissecting polycystic metabolic ovarian syndrome heterogeneity (PMOS): multi-omics, AI subtyping, and precision management
Polycystic metabolic ovarian syndrome (PMOS) is the most common endocrine disorder, affecting 8-12% of women of reproductive age and increasing the risk of infertility, type 2 diabetes, and heart disease.
By Sristy PradhanPubMed - AI Research
Read the full story
Originally published by PubMed - AI Research on Oct 23, 2026.
Comments
Sign in to join the discussion.